Enhanced Analyte Concentration Alert Function for Analyte Sensor Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses an improved analyte concentration alert function for analyte sensor systems, incorporating acceleration data to enhance the accuracy and reliability of glucose concentration value calculations, and providing more effective alerts for users.
Background and Problem Solved
The original patent described an analyte concentration alert function for analyte sensor systems, which relied solely on analyte data for calculating glucose concentration values. However, this approach had limitations, such as potential inaccuracies due to user movement. The present inventive concept addresses this limitation by incorporating acceleration data from an accelerometer, enabling more accurate glucose concentration value calculations and improved alert functionality.
Detailed Description of the Inventive Concept
The enhanced analyte concentration alert function comprises an analyte sensor, an accelerometer, a processor, and a notification module. The analyte sensor generates glucose data, while the accelerometer generates acceleration data corresponding to user movement. The processor calculates a glucose concentration value based on both the glucose data and acceleration data. The notification module then generates an alert when the calculated glucose concentration value falls below a predetermined threshold and the acceleration data indicates a sudden change in movement. Additionally, the system may incorporate a machine learning module to learn the user's activity patterns and adapt the alert threshold accordingly, or a haptic feedback module to provide a tactile alert to the user.
Novelty and Inventive Step
The present inventive concept introduces the novel combination of acceleration data and machine learning algorithms to improve the accuracy and reliability of glucose concentration value calculations. This innovation enables more effective alerts for users, providing a significant improvement over the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include incorporating additional sensors, such as heart rate or skin conductance sensors, to further enhance the accuracy of glucose concentration value calculations. Variations may also include different notification methods, such as audible or vibrational alerts, or integration with other health monitoring systems.
Potential Commercial Applications and Market
The enhanced analyte concentration alert function has significant commercial potential in the healthcare industry, particularly for individuals with diabetes. The improved accuracy and reliability of glucose concentration value calculations can lead to better health outcomes and increased user confidence. The market for this inventive concept is substantial, with potential applications in wearable devices, mobile health monitoring systems, and telemedicine platforms.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B5/746 |
| A | A61 | A61B5/0002 |
| A | A61 | A61B5/0004 |
| A | A61 | A61B5/01 |
| A | A61 | A61B5/1112 |
| A | A61 | A61B5/1118 |
| A | A61 | A61B5/145 |
| A | A61 | A61B5/1459 |
| A | A61 | A61B5/14532 |
| A | A61 | A61B5/7282 |
| A | A61 | A61B5/742 |
| A | A61 | A61B5/7405 |
| A | A61 | A61B5/7455 |
| A | A61 | A61B5/0533 |
| A | A61 | A61B5/14503 |
| A | A61 | A61B5/6898 |
| A | A61 | A61B5/7203 |
| A | A61 | A61B2562/0219 |
Original Patent Information
| Patent Number | US 11,857,350 |
|---|---|
| Title | Analyte concentration alert function for analyte sensor system |
| Assignee(s) | Senseonics, Incorporated |